In8bio Inc (INAB) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
In8bio Inc   (NASDAQ: INAB)


In8bio Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is In8bio Inc's ROI in the second quarter of 2026?
In8bio Inc recorded a cumulative net loss of $-19 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -81.95%.

Within the Healthcare sector 565 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2261 to 3941.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 52.94 % 64.09 % 53.09 % 3.8 % -19.33 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 19 25 30 16 18
Return On Investment (TTM) -81.95 % -84.38 % -93.7 % -123.09 % -160.41 %
INAB's Overall Ranking # 3941 # 2261 # 3159 # 3510 # 3413
Seq. Investment Change TTM 1.26 % 8.42 % 23.63 % 12.69 % 8.64 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -19 -19 -19 -21 -24

INAB Company Profile >> Back to INAB Roi Comparisons >> See Annual INAB Return On Investment



Return On Investment INAB's Ranking
Within: No.
Industry # 93
Sector # 566
Overall # 3941

Return On Investment Statistics
High Average Low
-7.99 %
-100.07 %
-174.84 %
(Dec 31 2021)   (Dec 31 2024)







Financial Statements
In8bio Inc's II. Quarter Investments $ 19 Millions INAB's Balance sheet
In8bio Inc's II. Quarter Income $ -5 Millions Quarterly INAB's Income Statement
INAB's Income by Division See INAB's Income by Division


INAB Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 28 14 25 23 38
Y / Y Investment Growth 90.34 % -41.94 % 9.7 % -40.47 % -
Net Income in Millions -19 -30 -30 -29 -15
Y / Y Net Income Growth - - - - -
Annual Return On Investment -70.54 % -210.23 % -120.33 % -125.47 % -38.38 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
INAB's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for INAB's Competitors
Subscribers only: Roi for In8bio Inc's Suppliers
Subscribers only: Return On Investment for INAB's Customers

Other Ratios
INAB's Roa INAB's Inventory Turnover Ratio INAB's Growth Rates INAB's Dividend Statistics
INAB's Profitability Ratios INAB's Asset Turnover Ratio INAB's Dividend Growth
INAB's Roe INAB's Valuation Ratios INAB's Financial Strength Ratios INAB's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:40:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.